Log out

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

Exela Technologies Inc (XELA)

$0.63 0.07 (12.83%)

19:59 EDT XELA Stock Quote Delayed 30 Minutes

Volume:

Previous Close $0.63

Market Cap 95.21M

PE Ratio -0.18

EPS -3.48

Volume (Avg. Vol.) 22.40M

Day's Range 0.55 - 0.66

52-Week Range 0.09 - 2.73

Dividend & Yield N/A (N/A)

XELA Stock Predictions, Articles, and Exela Technologies Inc News

From InvestorPlace
From the Web

7 Penny Stocks for the Valiant Investor

By Laura Hoy, InvestorPlace Contributor Jul 31, 2020

While penny stocks carry a high degree of risk, they could be a good place to look for value in today's market for investors that are willing to make short-term trades. These seven have potential catalysts on the horizon that make them worth considering.

Regenxbio Inc. (RGNX) Q2 2020 Earnings Call Transcript

From The Motley Fool Aug 7, 2020

RGNX earnings call for the period ending June 30, 2020.

Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates

From Zacks Investment Research Aug 6, 2020

Regenxbio (RGNX) delivered earnings and revenue surprises of -2.25% and -14.56%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Regenxbio EPS misses by $0.06, misses on revenue (NASDAQ:RGNX)

From Seeking Alpha Aug 6, 2020

Regenxbio (NASDAQ:RGNX): Q2 GAAP EPS of -$0.91 misses by $0.06.Revenue of $16.57M (+110.3% Y/Y) misses by $5.66M.Cash, cash equivalents and marketable securities of $339M.Press Release

Regenxbio announces positive one-year data on wet AMD gene therapy (NASDAQ:RGNX)

From Seeking Alpha Aug 4, 2020

REGENXBIO (NASDAQ:RGNX) announces positive one-year data from cohorts 4 & 5 of its Phase 1/2a clinical trial evaluating gene therapy RGX-314 in patients with wet age-related macular degeneration (wet AMD).The treatment effect was stable with a mean +4 letter change in best corrected visual acuity (BCVA) and -2 letters from baseline.

RGNX Makes Bullish Cross Above Critical Moving Average

From Market News Video May 18, 2020

In trading on Monday, shares of REGENXBIO Inc (RGNX) crossed above their 200 day moving average of $39.11, changing hands as high as $40.00 per share. REGENXBIO Inc shares are currently trading up about 3.2% on the day..

Regenxbio Inc. (RGNX) Q1 2020 Earnings Call Transcript

From The Motley Fool May 8, 2020

RGNX earnings call for the period ending March 31, 2020.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold